Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
15%
ALSO IN THNR
THNR
19
HOLDINGS
37%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 8.4% | 6.0% | 6.0% |
|
PFIZER INC | 6.4% | 5.1% | 5.1% |
|
ABBVIE INC | 6.3% | 4.9% | 4.9% |
|
ELI LILLY & CO | 4.1% | 12.4% | 4.1% |
|
AMGEN INC | 3.8% | 7.8% | 3.8% |
FTXH Overweight Relative to THNR
|
JOHNSON & JOHNSON | 8.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.5% |
|
CARDINAL HEALTH INC | 4.4% |
|
BIOGEN IDEC INC | 4.1% |
|
VIATRIS, INC. | 4.0% |
|
GILEAD SCIENCES INC | 3.8% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.2% |
 |
JAZZ PHARMACEUTICALS PLC | 2.5% |
|
MERCK & CO. INC. | 2.4% |
FTXH Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.9% |
|
ELI LILLY & CO | -8.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -7.9% |
|
SHIONOGI & CO LTD | -6.4% |
 |
ROCHE HOLDING LTD | -5.7% |
 |
ASTRAZENECA PLC | -5.6% |
 |
INNOVENT BIOLOGICS, INC. | -4.7% |
 |
CHINA PHARMACEUTICAL GROUP | -4.4% |
|
AMGEN INC | -4.0% |
|
REGENERON PHARMACEUTICALS | -2.8% |